This announcement is a separate document:
百诚医药：监事会关于2022年限制性股票激励计划首次及授予部分第一个归属期归属名单的核查意见
Baicheng Pharmaceutical: Audit opinion of the Board of Supervisors on the first and part of the first vesting period of the 2022 Restricted Stock Incentive Plan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.